title: Treatment of recurrent posttransplant lymphoproliferative disorder of the central nervous system with high-dose methotrexate.
abstract: Posttransplant lymphoproliferative disorder (PTLD) is a frequent complication of intestinal transplantation and is associated with a poor prognosis. There is currently no consensus on optimal therapy. Recurrent PTLD involving the central nervous system (CNS) represents a particularly difficult therapeutic challenge. We report the successful treatment of CNS PTLD in a pediatric patient after liver/small bowel transplantation. Initial immunosuppression (IS) was with thymoglobulin, solucortef, tacrolimus, and mycophenolate mofetil. EBV viremia developed 8 weeks posttransplantation, and despite treatment with cytogam and valganciclovir the patient developed a polymorphic, CD20+, EBV+ PTLD with peripheral lymphadenopathy. Following treatment with rituximab, the lymphadenopathy resolved, but a new monomorphic CD20-, EBV+, lambda-restricted, plasmacytoid PTLD mesenteric mass emerged. Complete response of this PTLD was achieved with 6 cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy; however, 4 months off therapy he developed CNS PTLD (monomorphic CD20-, EBV+, lambda-restricted, plasmacytoid PTLD) of the brain and spine. IS was discontinued and HD-MTX (2.5-5 gm/m(2)/dose) followed by intrathecal HD-MTX (2 mg/dose ×2-3 days Q 7-10 days per cycle) was administered Q 4-7 weeks. After 3 cycles of HD-MTX, the CSF was negative for malignant cells, MRI of head/spine showed near-complete response, and PET/CT was negative. The patient remains in complete remission now for 3.5 years after completion of systemic and intrathecal chemotherapy. Conclusion. HD-MTX is an effective therapy for CNS PTLD and recurrent PTLD that have failed rituximab and CHOP chemotherapy.
authors: Division of Hematology-Oncology, Department of Pediatrics, Lucile Salter Packard Children's Hospital, Suite 300, 1000 Welch Road, Palo Alto, CA 94304, USA.
authors: Clare J
authors: CJ
authors: Twist
authors: Ricardo O
authors: RO
authors: Castillo
references: J Clin Oncol. 2007 Nov 1;25(31):4902-8
references: 17971586
references: Transplant Proc. 2005 Mar;37(2):954-5
references: 15848587
references: Br J Haematol. 2008 Jan;140(2):191-6
references: 18173755
references: Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):551-4
references: 18842507
references: Pediatr Transplant. 2009 May;13(3):307-10
references: 18346039
references: Pediatr Transplant. 2002 Dec;6(6):456-64
references: 12453197
references: Pediatr Transplant. 2006 Jun;10(4):505-12
references: 16712612
references: Cancer. 1999 Jan 15;85(2):511-6
references: 10023723
references: Annu Rev Med. 2005;56:29-44
references: 15660500
references: Am J Transplant. 2009 May;9(5):1243-8
references: 19422350